𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Breast cancer risks in individuals testing negative for a known family mutation inBRCA1orBRCA2

✍ Scribed by S. M. Domchek; M. M. Gaudet; J. E. Stopfer; M. H. Fleischaut; J. Powers; N. Kauff; K. Offit; K. L. Nathanson; M. Robson

Publisher
Springer US
Year
2009
Tongue
English
Weight
170 KB
Volume
119
Category
Article
ISSN
0167-6806

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

No mutations in the XRCC2 gene in BRCA1/
No mutations in the XRCC2 gene in BRCA1/2-negative high-risk breast cancer families
✍ Raquel RodrΓ­guez-LΓ³pez; Ana Osorio; Luis SΓ‘nchez-Pulido; Miguel de la Hoya; Alic πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 French βš– 43 KB

About 5-10% of breast cancer cases are hereditary and attributable to mutations in several susceptibility genes from which to date only 2 have been identified: BRCA1 (17q21) and BRCA2 (13q12). However, the BRCA genes only explain about 30% of familial breast/ovarian cancer, suggesting the existence

No evidence for a role ofBRCA1 orBRCA2 m
No evidence for a role ofBRCA1 orBRCA2 mutations in Ashkenazi Jewish families with hereditary prostate cancer
✍ Wilkens, Eric P.; Freije, Diha; Xu, Jianfeng; Nusskern, Deborah R.; Suzuki, Hiro πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 167 KB πŸ‘ 2 views

## BACKGROUND. Two genes responsible for hereditary breast cancer (BRCA1 and BRCA2) have been identified, and predisposing mutations identified. Several studies have provided evidence that germline mutations in BRCA1 and BRCA2 confer an increased risk of prostate cancer. Based on these findings, o